Intratumoral Hypoxia as the Genesis of Genetic Instability and Clinical Prognosis in Prostate Cancer
- 23 October 2013
- book chapter
- review article
- Published by Springer Science and Business Media LLC in Advances in Experimental Medicine and Biology
- Vol. 772, 189-204
- https://doi.org/10.1007/978-1-4614-5915-6_9
Abstract
Intratumoral hypoxia is prevalent in many solid tumors and is a marker of poor clinical prognosis in prostate cancer. The presence of hypoxia is associated with increased chromosomal instability, gene amplification, downregulation of DNA damage repair pathways, and altered sensitivity to agents that damage DNA. These genomic changes could also lead to oncogene activation or tumor suppressor gene inactivation during prostate cancer progression. We review here the concept of repair-deficient hypoxic tumor cells that can adapt to low oxygen levels and acquire an aggressive “unstable mutator” phenotype. We speculate that hypoxia-induced genomic instability may also be a consequence of aberrant mitotic function in hypoxic cells, which leads to increased chromosomal instability and aneuploidy. Because both hypoxia and aneuploidy are prognostic factors in prostate cancer, a greater understanding of these biological states in prostate cancer may lead to novel prognostic and predictive tests and drive new therapeutic strategies in the context of personalized cancer medicine.This publication has 76 references indexed in Scilit:
- Cancer chromosomal instability: therapeutic and diagnostic challengesEMBO Reports, 2012
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1Cancer Cell, 2010
- Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130Proceedings of the National Academy of Sciences of the United States of America, 2010
- Whole Chromosome Instability Caused by Bub1 Insufficiency Drives Tumorigenesis through Tumor Suppressor Gene Loss of HeterozygosityCancer Cell, 2009
- DNA mismatch repair: Molecular mechanism, cancer, and ageingMechanisms of Ageing and Development, 2008
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyThe Lancet Oncology, 2008
- DNA damage induces Chk1‐dependent centrosome amplificationEMBO Reports, 2007
- BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerCancer Cell, 2006
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005